Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet    (SUNP)

Free Report: The Biggest Wealth Creating Opportunity in India. Download Now...

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 404.5
Mkt Cap Rs m 973,532
Vol '000 180.4
P/E X 22.0
P/CF X 19.6
EPS (TTM) Rs 18.3
% ch % 0.3
No. of shares m 2,406.75
% ch week % -2.4
% ch 1-mth % -10.0
% ch 12-mth % -2.4
52 week H/L Rs 484.1/350.4
(As on Feb 20, 2020 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs1,0741,201842701679 
Low Rs570706572433375 
Sales per share (Unadj.) Rs132.3118.4131.6110.4121.1 
Earnings per share (Unadj.) Rs21.923.532.710.713.4 
Diluted earnings per shareRs18.923.532.610.713.3 
Cash flow per share (Unadj.) Rs27.727.837.917.020.7 
Dividends per share (Unadj.) Rs3.001.003.502.002.75 
Adj. dividends per shareRs2.581.003.491.992.74 
Dividend yield (eoy) %0.40.10.50.40.5 
Book value per share (Unadj.) Rs135.2137.1152.7159.7172.6 
Adj. book value per shareRs116.4137.0152.2159.2172.1 
Shares outstanding (eoy) m2,071.162,406.602,399.262,399.262,399.26 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x6.28.15.45.14.4 
Avg P/E ratio x37.540.621.753.039.4 
P/CF ratio (eoy) x29.734.318.633.425.5 
Price / Book Value ratio x6.17.04.63.53.1 
Dividend payout %13.74.310.718.720.6 
Avg Mkt Cap Rs m1,703,0112,294,8131,696,8771,360,0211,264,650 
No. of employees `000NA14.717.517.817.5 
Total wages/salary Rs m45,02647,72349,02353,67159,671 
Avg. sales/employee Rs ThNM19,317.218,028.314,890.916,608.1 
Avg. wages/employee Rs ThNM3,236.12,798.83,017.13,409.6 
Avg. net profit/employee Rs ThNM3,836.94,473.81,443.61,833.8 
SUN PHARMA INCOME DATA
Net Sales Rs m273,920284,870315,784264,895290,659 
Other income Rs m5,4776,5836,2328,38810,255 
Total revenues Rs m279,397291,453322,016273,282300,914 
Gross profit Rs m78,66781,583100,89356,08163,076 
Depreciation Rs m11,94710,37512,64814,99817,533 
Interest Rs m5,7905,2323,9985,1765,553 
Profit before tax Rs m66,40772,55890,47944,29550,246 
Minority Interest Rs m-9,3630000 
Prior Period Items Rs m-12615000 
Extraordinary Inc (Exp) Rs m-2,378-6,8520-9,505-12,144 
Tax Rs m9,1479,13812,1169,1106,009 
Profit after tax Rs m45,39456,58378,36325,67932,093 
Gross profit margin %28.728.631.921.221.7 
Effective tax rate %13.812.613.420.612.0 
Net profit margin %16.619.924.89.711.0 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m288,782299,413329,537316,359310,692 
Current liabilities Rs m153,294131,440178,870198,643173,396 
Net working cap to sales %49.559.047.744.447.2 
Current ratio x1.92.31.81.61.8 
Inventory Days Days7682799599 
Debtors Days Days688783108112 
Net fixed assets Rs m151,694180,477204,766213,178232,477 
Share capital Rs m2,0712,4072,3992,3992,399 
"Free" reserves Rs m278,009327,418363,997380,742411,691 
Net worth Rs m280,080329,825366,397383,141414,091 
Long term debt Rs m13,59831,10314,36117,72115,226 
Total assets Rs m501,601555,303614,102645,164646,938 
Interest coverage x12.514.923.69.610.0 
Debt to equity ratio x00.1000 
Sales to assets ratio x0.50.50.50.40.4 
Return on assets %10.211.113.44.85.8 
Return on equity %16.217.221.46.77.8 
Return on capital %20.519.724.810.010.2 
Exports to sales %16.913.9000 
Imports to sales %4.53.1000 
Exports (fob) Rs m46,23539,572000 
Imports (cif) Rs m12,2298,882000 
Fx inflow Rs m48,70642,17144,11851,40366,025 
Fx outflow Rs m25,56421,58324,48432,23338,610 
Net fx Rs m23,14220,58819,63419,17027,415 
SUN PHARMA CASH FLOW
From Operations Rs m 56,157 66,859 70,822 39,072 21,965 
From Investments Rs m -28,657 -43,716 -42,216 -33,708 -6,813 
From Financial Activity Rs m -11,865 -18,885 -22,854 -15,393 -27,305 
Net Cashflow Rs m 15,635 8,482 6,107 -7,359 -8,442 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.7

Read: SUN PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GLENMARK PHARMA  ELDER PHARMA  AMAR REMEDIES  J.B.CHEMICALS  FDC LTD.  

Compare SUN PHARMA With:   GLENMARK PHARMA  ELDER PHARMA  AMAR REMEDIES  J.B.CHEMICALS  FDC LTD.  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Slow Economy? There's Still Good Money to Be Made in the Markets(Podcast)

Indian stock markets mostly remained in the negative zone during the week except for Wednesday.

Views on news

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

CoronaVirus' Impact on Indian Markets - And One Stock With the Potential to Make Crores... (Profit Hunter)

Feb 7, 2020

Even as the experts come to grips with impact of Coronavirus contagion on Indian stocks and economy, here's a stock not just immune to macro threats, but with the potential to offer crores in the long term.

Will Algo Traders Take Away All Your Profits? (Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

A Megatrend to Help You Find the Best Stocks of the Next Decade (The 5 Minute Wrapup)

Feb 12, 2020

Recent events have put climate change into the spotlight. Here's how you should play this megatrend...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS